Drugs against malaria, tuberculosis, HIV and other infectious diseases are still urgently needed in poorer countries. According to World Health Organisation (WHO) estimates, almost 430,000 people died
Scientists from the German Center for Infection Research (DZIF) are on a specific quest for the causes of and biomarkers for severe courses of Pfeiffer’s disease. The disease is caused by the Epstein
Florian Klein’s main goal is to improve HIV therapy with the help of antibodies and to develop a HIV vaccine. His research on a new generation of broadly neutralising antibodies has found worldwide
An international team of scientists and clinicians have, for the first time, examined the spread of particularly dreaded multidrug-resistant Enterobacteriaceae throughout Europe and collected
Scientists from the Heidelberg University Hospital and the German Center for Infection Research (DZIF) have succeeded in elucidating and specifically activating protective mechanisms against malaria
An international team of researchers have isolated and analyzed genetically tuberculosis bacteria from several thousand patients from over a hundred countries. This analysis demonstrates that the
For the first time, a German Liver Foundation trial shows that the chronic hepatitis C drugs developed in the last years can also cure acute hepatitis C—even faster than the chronic disease. The trial
The antibiotic daptomycin is often the last-resort treatment of multidrug-resistant bacteria. Up to now, it has been unclear how the drug works. A new study conducted with the DZIF now sheds light on
The natural substance researcher Prof Rolf Müller has been awarded the 2016 PHOENIX Pharmaceutical Science Award worth 10,000 euro. Müller heads the Helmholtz Institute for Pharmaceutical Research
The University of Tübingen has established a DZIF professorship in Africa for the first time, funded by the DZIF and the Government of Gabon. Dr Ayola Akim Adegnika has been appointed, he is currently
